RSI (14-Day Momentum)
Bearish Momentum
41.19
0 Oversold
50 Neutral
100 Overbought
Neurocrine Biosciences, Inc. NBIX
NasdaqGS • Real-Time Technical Indicators & Signals • Currency: USD
$143.18
+2.47 (+1.76%)
Market Closed (Last Close)
Daily MACD (12, 26, 9)
Bullish Crossover (Golden Cross)
+0.01
Hist
MACD Line: -4.52 | Signal Line: -4.53
Moving Averages (Trend)
Below 200 EMA
-4.93%
vs 200 EMA
20 EMA: $145.81
50 EMA: $152.36
200 EMA: $150.61
🤖
Automated Algorithmic Diagnosis
REAL-TIMEAlgorithmic Technical Summary for Neurocrine Biosciences, Inc. (NBIX): As of current market pricing, NBIX is trading at $143.18 (+2.47 (+1.76%)). Technical indicator diagnostics show a 14-day Relative Strength Index (RSI) of 41.19, indicating a Bearish Momentum condition. The daily MACD (Moving Average Convergence Divergence) indicator is currently registered at -4.52 versus the signal line of -4.53, giving a histogram reading of +0.01 (Bullish Crossover (Golden Cross)). From a structural trend perspective, NBIX is trading -4.93% below its 200-day exponential moving average ($150.61), classifying the prevailing institutional trend bias as Neutral Consolidation.
NBIX Price & Trend Overlay (Last 90 Days)
Price ($143.18)
20 EMA ($145.81)
50 EMA ($152.36)
Technical Indicators & Market Metrics Table
| Indicator / Metric | Current Value | Technical Status | Market Interpretation |
|---|---|---|---|
| RSI (14) | 41.19 | Bearish Momentum | RSI at 41.19 indicates moderate bearish pressure and weak buying appetite. |
| MACD Line (12, 26) | -4.52 | Bullish Crossover (Golden Cross) | Signal line: -4.53, Histogram: 0.01 |
| 20-Day EMA | $145.81 | Bearish | Short-term momentum guide. Price is trading under $145.81. |
| 50-Day EMA | $152.36 | Bearish | Medium-term trend indicator. Institutional support/resistance band. |
| 200-Day EMA | $150.61 | Long-Term Downtrend | Major institutional baseline. Distance to 200 EMA: -4.93%. |
| Average True Range (ATR 14) | $4.13 | Volatility | Expected average daily dollar price fluctuation. |
| 52-Week Range | $122.14 - $186.12 | Annual Range | Current price is $143.18 within the 52-week envelope. |
| Volume vs 30d Avg | 1.65M / 1.25M | Liquidity | Market Cap: 14.55B • P/E Ratio: 21.0 |
🔥 Market Movers & Technical Indicator Setups Today
Traders tracking NBIX are also monitoring these high-volatility setups across US markets.
$SOFI
🟢 Oversold Watch
SoFi Technologies
RSI in lower accumulation zone. Potential bottom reversal.
Inspect RSI & MACD →
$TSLA
🚀 Bullish Momentum
Tesla, Inc.
Midline RSI expansion and positive MACD histogram.
Inspect RSI & MACD →
$NVDA
⚡ AI Mega-Cap
NVIDIA Corporation
Holding above 50 & 200 EMA key support band.
Inspect RSI & MACD →
$PLTR
📈 Trend Follower
Palantir Technologies
Institutional volume inflow with MACD breakout.
Inspect RSI & MACD →
$AMD
⚠️ Volatility Play
Advanced Micro Devices
Testing multi-week technical resistance levels.
Inspect RSI & MACD →
$ASTS
🛰️ Retail Momentum
AST SpaceMobile
High relative volume with active indicator cross.
Inspect RSI & MACD →
Frequently Asked Questions about Neurocrine Biosciences, Inc. (NBIX)
Q: What is NBIX's RSI (Relative Strength Index) today?
As of today, Neurocrine Biosciences, Inc. (NBIX) has a 14-day RSI of 41.19. This indicates a Bearish Momentum condition. Traders use RSI readings below 30 to identify oversold conditions and readings above 70 to identify overbought conditions.
Q: Is NBIX's MACD indicator bullish or bearish?
The daily MACD line for NBIX is currently -4.52 compared to its 9-day signal line of -4.53, generating a histogram difference of +0.01. This translates to a Bullish Crossover (Golden Cross) signal.
Q: Where is NBIX trading relative to its 200-day EMA?
NBIX is currently trading at $143.18, which is -4.93% below its 200-day exponential moving average of $150.61. Staying above the 200 EMA is considered a primary benchmark for institutional bull market trends.
Q: What are key support and resistance levels for NBIX?
Immediate support sits around the 20-day EMA ($145.81) and recent 20-day swing low ($138.35). Immediate resistance is marked near the 20-day high ($157.22) and the 52-week high of $186.12.